Eric H. Sasso

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

Zehra Kaymakcalan, Paul Sakorafas, Sahana Bose et al. · Clinical Immunology · 2009 · 309 citations

Inflammation, Complement System, Anti-inflammatory +8

Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial

Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2007 · 296 citations

Human IgA and IgG F(ab’)2 that bind to staphylococcal protein A belong to the VHIII subgroup

Eric H. Sasso, GJ Silverman, Mart Mannik · The Journal of Immunology · 1991 · 213 citations · Full text

Human IgM molecules that bind staphylococcal protein A contain VHIII H chains.

Eric H. Sasso, Gregg J. Silverman, Mart Mannik · The Journal of Immunology · 1989 · 197 citations · Full text

Spa Binding, Protein Assembly, Bacteriology +17

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Mark C. Genovese, Philip J. Mease, G. T. D. Thomson et al. · PubMed · 2007 · 190 citations